What sets ExomeXtra® apart as 'better than exome, smarter than genome'? ExomeXtra® combines the advantages of whole genome sequencing (WGS), whole exome sequencing (WES), and array CGH while avoiding their disadvantages. Unlike standard WGS, which often has insufficient coverage for reliable variant detection, ExomeXtra® offers higher sensitivity and more thorough coverage of relevant genomic regions. Its unique design goes beyond the coding regions of the exome: It also encompasses the entire mitochondrial genome and all known disease-causing regions, including copy number variants in the whole genome. This smart design, combined with our extra thorough analysis and medical data interpretation for insightful results, makes ExomeXtra® the most comprehensive genetic test available. Learn more: https://lnkd.in/ec6vX9DJ
CeGaT GmbH’s Post
More Relevant Posts
-
Great news! We have expanded our preventive and predictive genetic diagnostics by adding tumor, kidney, and metabolic diseases, as well as Alzheimer's dementia and Parkinson's. This comprehensive update enhances our ability to provide valuable insights into an individual's genetic predisposition, supporting the adaptation of lifestyle and life choices. Read our news to find out in detail what's new: https://lnkd.in/enG-RmJs #GeneticDiagnostics #Prevention #Health #Dementia #Parkinsons
-
-
🚀 𝗖𝗲𝗚𝗮𝗧 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝘀 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗰𝗶𝘁𝘆 We are excited to share that we've added a second NovaSeqᵀᴹ X Plus system to our lab, expanding our sequencing capacities alongside our five NovaSeqᵀᴹ 6000s and the first NovaSeqᵀᴹ X Plus we acquired last year. This is great news against the backdrop of ever-increasing demand for our outstanding sequencing services! For more information, take a look at our news text: https://lnkd.in/eS2SpT6V #sequencing #novaseqxplus #lab #capacity #illumina
-
-
𝗖𝗮𝗻𝗰𝗲𝗿𝗗𝗲𝘁𝗲𝗰𝘁® 𝗻𝗼𝘄 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝘀 𝗳𝘂𝘀𝗶𝗼𝗻𝘀 𝗶𝗻 𝗰𝗳𝗗𝗡𝗔 As part of our regular updates, we have added a significant upgrade to our CancerDetect® panel: The liquid biopsy-based analysis now detects selected, therapy-relevant gene fusions and thus provides important information for oncological treatment planning. Learn more: https://lnkd.in/ehKSGFqS #update #tumor #diagnostics #genetics #liquidbiopsy #news
-
-
𝗧𝗵𝗲𝗿𝗲 𝗮𝗿𝗲 𝗼𝗻𝗹𝘆 𝘁𝘄𝗼 𝗱𝗮𝘆𝘀 𝗹𝗲𝗳𝘁 𝘂𝗻𝘁𝗶𝗹 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗖𝗲𝗚𝗮𝗧 𝗘𝘅𝗼𝗺𝗲𝗫𝘁𝗿𝗮®! Join us on June 20, when Dr. Stefan Griesbach and Dr. Heinz Gabriel will present our webinar, "How ExomeXtra® Solves Patient Cases: A Four-Year Retrospective." Register now and learn how ExomeXtra® can shorten your patient's diagnostic odyssey to one month: https://lnkd.in/gX3NheFY #NGS #Exome #Webinar #RareDisease #Diagnostics #FreeWebinar #JoinUs
-
Meet Eric R. Miller at the CCMG-CCGM 48th Annual Scientific Meeting from June 16-19. Visit him at booth no.14 and learn more about CeGaT's genetic diagnostics portfolio. #genetics #NGS #meetus #CCMG #meeting #conference
-
-
Single-Cell RNA Sequencing becomes flexible! Our new Single-Cell RNA Sequencing Flex (SCR Flex) now allows expression profiling at single-cell resolution even from FFPE tissue. Discover our extended product portfolio and benefit from sample selection flexibility. Learn more here: https://lnkd.in/eUFnNixK #sequencing #rna #singlecell #expression #ffpe #rsearch #science
-
-
Take part in our upcoming webinar on exome diagnostics on June 20: Using examples from daily diagnostic practice, we will explain the advantages and benefits of our ExomeXtra®. ExomeXtra® is more than just another test, it is a breakthrough in genetic diagnostics. It covers all protein-coding and over 38,000 non-coding clinically relevant regions. The entire mitochondrial genome is covered, as well as clinically relevant RNA genes. And we have included a genome-wide backbone so that our ExomeXtra® automatically includes an array CGH analysis - providing the most comprehensive database for informed genetic diagnosis. Register today for our free webinar on June 20: https://lnkd.in/gX3NheFY. We look forward to your participation. #webinar #freewebinar #joinus #exomediagnostics #exomextra
-
-
Hi from ESHG! Join us at booth 628 for insightful discussions. Stop by or schedule an appointment with one of our experts: https://lnkd.in/eWpNNjGW #eshg #meetus #genetics #genetictesting #NGS #conference
-
-
Join Dr. Pauline Latzer's talk on 'Personalized peptide vaccination among 173 patients with glioblastoma' at ESHG 2024. Learn how personalized vaccines have shown to be a promising potential treatment option for GBM patients: 📅 Saturday, June 1 | ⏰ 7:30 - 7:45 p.m. | 📍 Room A2 Dr. Latzer will present the clinical courses and immune monitoring results of 173 GBM patients from October 2015 to August 2023. These patients received personalized peptide vaccines targeting tumor-specific neoantigens as part of their treatment. This real-world observation, the largest of its kind, not only shows the feasibility of this innovative approach but also its immunogenicity and clinical effectiveness, highlighting promising results.
-